Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 267 is a multi-pass membrane protein encoded by the TMEM267 gene on human chromosome 5. It is conserved across vertebrates and predicted to be localized in cellular membranes. While annotated as a structural or transporter protein, its exact molecular function and involvement in biological processes are currently unknown. There is no experimental evidence supporting its therapeutic relevance, disease association, or role as a drug target. It has several transcript variants and is expressed in a range of normal and cancer tissues, but lacks functional, mechanistic, or clinical characterization. The most commonly used names and aliases include TMEM267, C5orf28, and FLJ21657. There is no evidence that TMEM267 is a therapeutic target, no reported interacting drugs, and its exact function and disease relevance remain undefined. No safety or biomarker data are available.
Not applicable (no known drugs target this protein)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 267 (TMEM267).